Specialty pharmacy mandates create administrative burdens on healthcare providers and pose serious risks to patients like me. My doctor should be focused on providing the best care for their patients, but a specialty pharmacy mandate makes that task an increasingly difficult, often insurmountable one. Specialty pharmacy mandates can delay access to drugs, increase administrative work for my doctor’s office, and could even push me out of my doctor’s office into the hospital. Specialty pharmacy mandates can increase administrative burdens on healthcare providers, while decreasing reimbursement. This could make it financially unsustainable for my doctor to continue to see BCBS TN patients like me, thereby displacing me to often more expensive sites of care. A specialty mandate could force patients to find new sites of care, often the hospital, because their healthcare provider can no longer treat them. This transition can bring stress and additional financial burdens on patients. • A specialty pharmacy mandate could drastically reduce the reimbursement paid to my healthcare providers, which jeopardizes their ability to treat patients. If my provider is no longer able to treat me, they will have to refer me to an alternate site of care, often a hospital, for treatment. Changing sites of care could delay my treatment or make my treatment more expensive. I do not feel comfortable changing sites of care. Receiving the right medication at the right time is imperative to the success of the treatment and delays can cause poor health outcomes. • Specialty pharmacies can present issues relating to drug quantities or volume, and drug wastage. My doctor could receive different quantities than what is ordered or experience shipping delays, which could delay my treatment, causing serious health implications. Healthcare provider offices are dedicated to minimizing my cost of care and making sure I can afford my medication. • My provider’s office assists me in navigating alternate payment options such as copay assistance cards and manufacturer coupons. Specialty pharmacies may not be as diligent with applying financial assistance, resulting in my treatments becoming unaffordable. While I appreciate BlueCross Blue Shield of Tennessee’s effort to reduce healthcare costs while improving patient experience and health outcomes, a specialty pharmacy mandate could threaten office-based infusion settings and decrease my access to low cost, quality care. I urge BCBS to reevaluate this detrimental policy for the good of all patients and healthcare providers in Tennessee. Thank you for your time, and I look forward to your response.

Specialty pharmacy mandates create administrative burdens on healthcare providers and pose serious risks to patients like me. My doctor should be focused on providing the best care for their patients, but a specialty pharmacy mandate makes that task an increasingly difficult, often insurmountable one. Specialty pharmacy mandates can delay access to drugs, increase administrative work for my doctor’s office, and could even push me out of my doctor’s office into the hospital. A specialty mandate could force patients to find new sites of care, often the hospital, because their healthcare provider can no longer treat them. This transition can bring stress and additional financial burdens on patients. • A specialty pharmacy mandate could drastically reduce the reimbursement paid to my healthcare provider, which jeopardizes their ability to treat patients. If my provider is no longer able to treat me, they will have to refer me to an alternate site of care, often a hospital, for treatment. Changing sites of care could delay my treatment or make my treatment more expensive. I do not feel comfortable changing where I receive my infusions. Receiving the right medication at the right time is imperative to the success of the treatment and delays can cause poor health outcomes. • Specialty pharmacies can present issues relating to drug quantities or volume, and drug wastage. My doctor could receive different quantities than what is ordered or experience shipping delays, which could delay my treatment, causing serious health implications. Healthcare provider offices are dedicated to minimizing my cost of care and making sure I can afford my medication. • My provider’s office assists me in navigating alternate payment options such as copay assistance cards and manufacturer coupons. Specialty pharmacies may not be as diligent with applying financial assistance, resulting in my treatments becoming unaffordable. While I appreciate BlueCross Blue Shield of Tennessee’s effort to reduce healthcare costs while improving patient experience and health outcomes, a specialty pharmacy mandate could threaten office-based infusion settings and decrease my access to low cost, quality care. I urge BCBS to reevaluate this detrimental policy for the good of all patients and healthcare providers in Tennessee. Thank you for your time, and I look forward to your response.

Specialty pharmacy mandates create administrative burdens on healthcare providers and pose serious risks to patients like me. My doctor should be focused on providing the best care for their patients, but a specialty pharmacy mandate makes that task an increasingly difficult, often insurmountable one. Specialty pharmacy mandates can delay access to drugs, increase administrative work for my doctor’s office, and could even push me out of my doctor’s office into the hospital. A specialty mandate could force patients to find new sites of care, often the hospital, because their healthcare provider can no longer treat them. This transition can bring stress and additional financial burdens on patients. • A specialty pharmacy mandate could drastically reduce the reimbursement paid to my healthcare provider, which jeopardizes their ability to treat patients. If my provider is no longer able to treat me, they will have to refer me to an alternate site of care, often a hospital, for treatment. Changing sites of care could delay my treatment or make my treatment more expensive. I do not feel comfortable changing where I receive my infusions. Receiving the right medication at the right time is imperative to the success of the treatment and delays can cause poor health outcomes. • Specialty pharmacies can present issues relating to drug quantities or volume, and drug wastage. My doctor could receive different quantities than what is ordered or experience shipping delays, which could delay my treatment, causing serious health implications. Healthcare provider offices are dedicated to minimizing my cost of care and making sure I can afford my medication. • My provider’s office assists me in navigating alternate payment options such as copay assistance cards and manufacturer coupons. Specialty pharmacies may not be as diligent with applying financial assistance, resulting in my treatments becoming unaffordable. While I appreciate BlueCross Blue Shield of Tennessee’s effort to reduce healthcare costs while improving patient experience and health outcomes, a specialty pharmacy mandate could threaten office-based infusion settings and decrease my access to low cost, quality care. I urge BCBS to reevaluate this detrimental policy for the good of all patients and healthcare providers in Tennessee. Thank you for your time, and I look forward to your response.

Specialty pharmacy mandates create administrative burdens on healthcare providers and pose serious risks to patients like me. My doctor should be focused on providing the best care for their patients, but a specialty pharmacy mandate makes that task an increasingly difficult, often insurmountable one. Specialty pharmacy mandates can delay access to drugs, increase administrative work for my doctor’s office, and could even push me out of my doctor’s office into the hospital. A specialty mandate could force patients to find new sites of care, often the hospital, because their healthcare provider can no longer treat them. This transition can bring stress and additional financial burdens on patients. • A specialty pharmacy mandate could drastically reduce the reimbursement paid to my healthcare provider, which jeopardizes their ability to treat patients. If my provider is no longer able to treat me, they will have to refer me to an alternate site of care, often a hospital, for treatment. Changing sites of care could delay my treatment or make my treatment more expensive. I do not feel comfortable changing where I receive my infusions. Receiving the right medication at the right time is imperative to the success of the treatment and delays can cause poor health outcomes. • Specialty pharmacies can present issues relating to drug quantities or volume, and drug wastage. My doctor could receive different quantities than what is ordered or experience shipping delays, which could delay my treatment, causing serious health implications. Healthcare provider offices are dedicated to minimizing my cost of care and making sure I can afford my medication. • My provider’s office assists me in navigating alternate payment options such as copay assistance cards and manufacturer coupons. Specialty pharmacies may not be as diligent with applying financial assistance, resulting in my treatments becoming unaffordable. While I appreciate BlueCross Blue Shield of Tennessee’s effort to reduce healthcare costs while improving patient experience and health outcomes, a specialty pharmacy mandate could threaten office-based infusion settings and decrease my access to low cost, quality care. I urge BCBS to reevaluate this detrimental policy for the good of all patients and healthcare providers in Tennessee. Thank you for your time, and I look forward to your response.

Specialty pharmacy mandates create administrative burdens on healthcare providers and pose serious risks to patients like me. My doctor should be focused on providing the best care for their patients, but a specialty pharmacy mandate makes that task an increasingly difficult, often insurmountable one. Specialty pharmacy mandates can delay access to drugs, increase administrative work for my doctor’s office, and could even push me out of my doctor’s office into the hospital. A specialty mandate could force patients to find new sites of care, often the hospital, because their healthcare provider can no longer treat them. This transition can bring stress and additional financial burdens on patients. • A specialty pharmacy mandate could drastically reduce the reimbursement paid to my healthcare provider, which jeopardizes their ability to treat patients. If my provider is no longer able to treat me, they will have to refer me to an alternate site of care, often a hospital, for treatment. Changing sites of care could delay my treatment or make my treatment more expensive. I do not feel comfortable changing where I receive my infusions. Receiving the right medication at the right time is imperative to the success of the treatment and delays can cause poor health outcomes. • Specialty pharmacies can present issues relating to drug quantities or volume, and drug wastage. My doctor could receive different quantities than what is ordered or experience shipping delays, which could delay my treatment, causing serious health implications. Healthcare provider offices are dedicated to minimizing my cost of care and making sure I can afford my medication. • My provider’s office assists me in navigating alternate payment options such as copay assistance cards and manufacturer coupons. Specialty pharmacies may not be as diligent with applying financial assistance, resulting in my treatments becoming unaffordable. While I appreciate BlueCross Blue Shield of Tennessee’s effort to reduce healthcare costs while improving patient experience and health outcomes, a specialty pharmacy mandate could threaten office-based infusion settings and decrease my access to low cost, quality care. I urge BCBS to reevaluate this detrimental policy for the good of all patients and healthcare providers in Tennessee. Thank you for your time, and I look forward to your response.